SHAREHOLDER ALERT: Weiss Law Reminds STOR, AVLR, LOTZ, and GMTX Shareholders About Its Ongoing Investigations
NEW YORK, Sept. 19, 2022 /PRNewswire/ --
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of STORE Capital Corporation (NYSE: STOR) in connection with the proposed acquisition of STOR by GIC and funds managed by Oak Street. Under the terms of the merger agreement, STOR shareholders will receive $32.25 in cash for each share of STOR common stock owned. If you own STOR shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/stor
Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Avalara, Inc. (NYSE: AVLR), in connection with the proposed acquisition of AVLR by Vista Equity Partners. Under the terms of the merger agreement, AVLR shareholders will receive $93.50 in cash for each share of AVLR common stock owned. If you own AVLR shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/avlr
Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CarLotz, Inc. (NASDAQ: LOTZ), in connection with the proposed merger of LOTZ with Shift Technologies, Inc. ("Shift"). Pursuant to the merger agreement, LOTZ shareholders will receive 0.692158 shares of Shift common stock for each share of LOTZ common stock. If you own LOTZ shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/lotz
Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Gemini Therapeutics, Inc. (NASDAQ: GMTX), in connection with the proposed merger of GMTX with Disc Medicine, Inc. ("Disc"). Pursuant to the merger agreement, GMTX shareholders are expected to own approximately 28% of the combined company and Disc shareholders are expected to own approximately 72% of the combined company. Prior to the closing of the proposed merger, GMTX shareholders will be issued contingent value rights ("CVR's) representing the right to receive certain payments from proceeds received by the combined company, if any, related to pre-transaction legacy assets during the period ending one year following the closing of the merger. If you own GMTX shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/gmtx
SOURCE Weiss Law
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article